Showing results (161-170 of 324) with videos related to
Sort By:
Pageof 33
Sarcoma|January 4, 2011
Targeting the p53 Pathway in Ewing SarcomaPaul M Neilsen, Kathleen I Pishas, David F Callen, et al.Medical Science Educator|August 7, 2023
A Qualitative Analysis on the Effectiveness of Peer Feedback in Team-Based LearningSarah Lerchenfeldt, Suzan Kamel-ElSayed, Gustavo Patino, et al.International Journal of Clinical Oncology|June 11, 2026
BRAF-targeted therapy in non-melanomatous BRAF-mutant tumours: a systematic review of broad but histology-modulated efficacyYael R Lefkovits, Luke S McLean, Mark R Middleton, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 2011
The relationship between unmet needs and distress amongst young people with cancerGavin J Dyson, Kate Thompson, Susan Palmer, et al.Journal of Neurochemistry|December 24, 2003
Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment--an oligonucleotide microarray approachDavid M Thomas, Dina M Francescutti-Verbeem, Xiuli Liu, et al.Blood|January 25, 2002
Regulation of fetal versus embryonic gamma globin genes: appropriate developmental stage expression patterns in the presence of HS2 of the locus control regionTimothy Yu, David M Thomas, Wei Zhu, et al.Mededportal : the Journal of Teaching and Learning Resources|September 3, 2020
Suicide Assessment and Management Team-Based Learning ModuleSarah Lerchenfeldt, Suzan Kamel-ElSayed, Gustavo Patino, et al.BMC Cancer|March 8, 2006
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaChristine L Chaffer, David M Thomas, Erik W Thompson, et al.Expert Review of Molecular Diagnostics|December 20, 2007
The promise of PET in clinical management and as a sensitive test for drug cytotoxicity in sarcomasKenneth K Khamly, Rodney J Hicks, Grant A McArthur, et al.BMC Cancer|December 23, 2006
High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancerMichael Krypuy, Genni M Newnham, David M Thomas, et al.Pageof 33